AusPAR: Diphtheria toxoid / Haemophilus type B polysaccharide / hepatitis B surface antigen / pertussis filamentous haemagglutinin / pertussis toxoid / poliovirus / tetanus protein / tetanus toxoid

Australian Public Assessment Report

AusPAR

AusPAR: DTPa-hepB-IPV-Hib vaccine [PDF, 856.92 KB]

AusPAR: DTPa-hepB-IPV-Hib vaccine [Word, 628.8 KB]

Attachment: Product Information: DTPa-hepB-IPV-Hib vaccine [PDF, 196.19 KB]

Attachment: Product Information: DTPa-hepB-IPV-Hib vaccine [Word, 76.7 KB]

Attachment: Extract from the Clinical Evaluation Report: DTPa-hepB-IPV-Hib vaccine [PDF, 2.4 MB]

Attachment: Extract from the Clinical Evaluation Report: DTPa-hepB-IPV-Hib vaccine [Word, 2.92 MB]

Device/Product Name

Hexaxim

Active ingredients

Diphtheria toxoid / Haemophilus type B polysaccharide / hepatitis B surface antigen / pertussis filamentous haemagglutinin / pertussis toxoid / poliovirus / tetanus protein / tetanus toxoid

AusPAR Date

12 January 2015

Published

28 January 2015

Submission Number

PM-2013-02800-1-2

Submission Type

New biological entity

Decision

Approved

This webpage on the TGA website was printed on 12 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/auspar/auspar-diphtheria-toxoid-haemophilus-type-b-polysaccharide-hepatitis-b-surface-antigen-pertussis-filamentous-haemagglutinin-pertussis-toxoid-poliovirus-tetanus-protein-tetanus-toxoid

Sub menu

AusPAR: Diphtheria toxoid / Haemophilus type B polysaccharide / hepatitis B surface antigen / pertussis filamentous haemagglutinin / pertussis toxoid / poliovirus / tetanus protein / tetanus toxoid

Help us improve the Therapeutic Goods Administration site